CA
NZ
UK
AU
IND
US
Fred Hassan filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing his status as a newly appointed director of Recursion Pharmaceuticals, Inc. as of October 31, 2026.
Lorie Ann Boyd, Chief People Officer of Kodiak AI, Inc., filed an initial statement of beneficial ownership (Form 3) on November 4, 2026, with an event date of November 2, 2026.
An amended initial statement of beneficial ownership (Form 3/A) was filed on November 4, 2026, by Soumen Das, Miteshkumar Patel, SPACCircle Sponsor LLC, and SPACCatalyst LLC, each reporting their relationship to SPACCircle Acquisition Corp. as of the event date of October 26, 2026.
AngioDynamics President and CEO Eric Honroth filed a Form 4 on November 4, 2026, disclosing the acquisition of restricted stock units and performance rights on November 2, 2026, resulting in beneficial ownership of 101,193 shares of common stock.
cbdMD, Inc. filed a Form 8-K on November 4, 2026, disclosing the October 30, 2026 completion of its acquisition of assets from Twinlab Consolidated Holdings, Inc. and related subsidiaries through its wholly owned subsidiary To Be Brands, LLC.
Akretive Holdings, LLC filed a Schedule 13D with the SEC on November 4, 2026, disclosing that it acquired 2,229,805 shares of cbdMD, Inc. common stock on October 30, 2026, representing approximately 15.9% of the company's outstanding shares.
Eric Honroth, newly appointed President and CEO of AngioDynamics Inc, filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing no securities beneficially owned as of the event date of November 2, 2026.
EHang Holdings Ltd Chief Executive Officer and Director Hu Huazhi filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing his holdings as of the event date of April 1, 2026.
Akretive Holdings LLC filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing direct beneficial ownership of 2,229,805 shares of common stock in cbdMD, Inc. (NYSE American:YCBD) following a triggering event dated October 30, 2026.
Director Clive Gerrard Brookes filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing his initial securities holdings in Agassi Sports Entertainment Corp. following his appointment to the company's board.
Please wait processing your request...